Chile approves use of Sinovac’s Coronavac for children 6 years and older

The decision of the experts and the Institute of Public Health was based on part of the analysis of phase I and phase II studies conducted in China in 600 children.

RIO DE JANEIRO, BRAZIL - Chilean health authorities on Monday approved the use of Sinovac's vaccine Coronavac for children six years of age and older. This decision was made after analyzing the results of phase I and II clinical trials conducted in China.

The decision was made after the National Supply Center (Cenabast) submitted a request to the Institute of Public Health (ISP) to settle the matter on Thursday, August 26.

Read also: Check out our coverage on Chile

Five experts recommended the ISP emergency vaccination for . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?